Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020.


Journal

Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049

Informations de publication

Date de publication:
10 Nov 2020
Historique:
received: 10 06 2020
accepted: 15 06 2020
pubmed: 20 6 2020
medline: 18 11 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Previous reports of coronavirus disease 2019 among children in the United States have been based on health jurisdiction reporting. We performed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing on children enrolled in active, prospective, multicenter surveillance during January-March 2020. Among 3187 children, only 4 (0.1%) SARS-CoV-2-positive cases were identified March 20-31 despite evidence of rising community circulation.

Identifiants

pubmed: 32556327
pii: 5859277
doi: 10.1093/jpids/piaa075
pmc: PMC7337823
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-612

Subventions

Organisme : NCIRD CDC HHS
ID : U01 IP001049
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001050
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001063
Pays : United States

Informations de copyright

Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2020.

Auteurs

Brian Rha (B)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Joana Y Lively (JY)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
IHRC Inc, contracting agency to the Division of Viral Diseases, Atlanta, Georgia, USA.

Janet A Englund (JA)

Seattle Children's Hospital, Seattle, Washington, USA.

Mary A Staat (MA)

Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Geoffrey A Weinberg (GA)

University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

Rangaraj Selvarangan (R)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Natasha B Halasa (NB)

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

John V Williams (JV)

UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Julie A Boom (JA)

Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Leila C Sahni (LC)

Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Marian G Michaels (MG)

UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Laura S Stewart (LS)

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Christopher J Harrison (CJ)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Peter G Szilagyi (PG)

Department of Pediatrics, UCLA Mattel Children's Hospital, University of California at Los Angeles, Los Angeles, California, USA.

Monica M McNeal (MM)

Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Eileen J Klein (EJ)

Seattle Children's Hospital, Seattle, Washington, USA.

Bonnie Strelitz (B)

Seattle Children's Hospital, Seattle, Washington, USA.

Kirsten Lacombe (K)

Seattle Children's Hospital, Seattle, Washington, USA.

Elizabeth Schlaudecker (E)

Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Mary E Moffatt (ME)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Jennifer E Schuster (JE)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Barbara A Pahud (BA)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Gina Weddle (G)

University of Missouri-Kansas City School of Medicine, Children's Mercy, Kansas City, Missouri, USA.

Robert W Hickey (RW)

UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Vasanthi Avadhanula (V)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.

Mary E Wikswo (ME)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aron J Hall (AJ)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aaron T Curns (AT)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Susan I Gerber (SI)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Gayle Langley (G)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH